Elective splenectomy in children with idiopathic thrombocytopenic purpura

E. Mantadakis, G. R. Buchanan

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Purpose: The aim of this study was to review the safety and efficacy of elective splenectomy in children with idiopathic (immune) thrombocytopenic purpura (ITP). Methods: The authors reviewed the medical records of children with ITP treated with elective splenectomy at Children's Medical Center of Dallas since 1961. Indication for splenectomy was symptomatic thrombocytopenia unresponsive to medical management. Results: Thirty-eight evaluable patients who had elective splenectomy for ITP were identified. Twenty-one (55%) were girls and 17 (45%) were boys. Twenty-two had splenectomy since January 1990. Age at diagnosis ranged from 6 months to 15.9 years (median 9 years), and age at splenectomy ranged from 3.6 to 16.4 years (median 11.8). Laparoscopic splenectomy was performed in 11 patients. No patient died and only one (2.6%) had postoperative hemorrhage. There were no other complications related to surgery. No cases of postsplenectomy sepsis were observed. At follow-up ranging from 1 month to 19.9 years (median 2.1 years), 29 patients (76.3%) had a normal platelet count (>150 × 109/L) and 4 (10.5%) had a platelet count between 50 and 150 × 109/L. Only two of the five (13.2%) remaining patients who continued to have a platelet count less than 50 × 109/L had hemorrhagic manifestations necessitating intermittent therapy with corticosteroids. Conclusion: Laparoscopic or open splenectomy is a safe and effective procedure for children with chronic or refractory ITP and should be considered when medical management fails or causes excessive toxicity.

Original languageEnglish (US)
Pages (from-to)148-153
Number of pages6
JournalJournal of Pediatric Hematology/Oncology
Volume22
Issue number2
DOIs
StatePublished - 2000

Fingerprint

Idiopathic Thrombocytopenic Purpura
Splenectomy
Platelet Count
Postoperative Hemorrhage
Thrombocytopenia
Medical Records
Sepsis
Adrenal Cortex Hormones
Safety

Keywords

  • Immune thrombocytopenic purpura
  • Laparoscopic splenectomy
  • Postsplenectomy sepsis
  • Splenectomy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Elective splenectomy in children with idiopathic thrombocytopenic purpura. / Mantadakis, E.; Buchanan, G. R.

In: Journal of Pediatric Hematology/Oncology, Vol. 22, No. 2, 2000, p. 148-153.

Research output: Contribution to journalArticle

@article{8466c9e2fd77486395b21e7a713574b4,
title = "Elective splenectomy in children with idiopathic thrombocytopenic purpura",
abstract = "Purpose: The aim of this study was to review the safety and efficacy of elective splenectomy in children with idiopathic (immune) thrombocytopenic purpura (ITP). Methods: The authors reviewed the medical records of children with ITP treated with elective splenectomy at Children's Medical Center of Dallas since 1961. Indication for splenectomy was symptomatic thrombocytopenia unresponsive to medical management. Results: Thirty-eight evaluable patients who had elective splenectomy for ITP were identified. Twenty-one (55{\%}) were girls and 17 (45{\%}) were boys. Twenty-two had splenectomy since January 1990. Age at diagnosis ranged from 6 months to 15.9 years (median 9 years), and age at splenectomy ranged from 3.6 to 16.4 years (median 11.8). Laparoscopic splenectomy was performed in 11 patients. No patient died and only one (2.6{\%}) had postoperative hemorrhage. There were no other complications related to surgery. No cases of postsplenectomy sepsis were observed. At follow-up ranging from 1 month to 19.9 years (median 2.1 years), 29 patients (76.3{\%}) had a normal platelet count (>150 × 109/L) and 4 (10.5{\%}) had a platelet count between 50 and 150 × 109/L. Only two of the five (13.2{\%}) remaining patients who continued to have a platelet count less than 50 × 109/L had hemorrhagic manifestations necessitating intermittent therapy with corticosteroids. Conclusion: Laparoscopic or open splenectomy is a safe and effective procedure for children with chronic or refractory ITP and should be considered when medical management fails or causes excessive toxicity.",
keywords = "Immune thrombocytopenic purpura, Laparoscopic splenectomy, Postsplenectomy sepsis, Splenectomy",
author = "E. Mantadakis and Buchanan, {G. R.}",
year = "2000",
doi = "10.1097/00043426-200003000-00013",
language = "English (US)",
volume = "22",
pages = "148--153",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Elective splenectomy in children with idiopathic thrombocytopenic purpura

AU - Mantadakis, E.

AU - Buchanan, G. R.

PY - 2000

Y1 - 2000

N2 - Purpose: The aim of this study was to review the safety and efficacy of elective splenectomy in children with idiopathic (immune) thrombocytopenic purpura (ITP). Methods: The authors reviewed the medical records of children with ITP treated with elective splenectomy at Children's Medical Center of Dallas since 1961. Indication for splenectomy was symptomatic thrombocytopenia unresponsive to medical management. Results: Thirty-eight evaluable patients who had elective splenectomy for ITP were identified. Twenty-one (55%) were girls and 17 (45%) were boys. Twenty-two had splenectomy since January 1990. Age at diagnosis ranged from 6 months to 15.9 years (median 9 years), and age at splenectomy ranged from 3.6 to 16.4 years (median 11.8). Laparoscopic splenectomy was performed in 11 patients. No patient died and only one (2.6%) had postoperative hemorrhage. There were no other complications related to surgery. No cases of postsplenectomy sepsis were observed. At follow-up ranging from 1 month to 19.9 years (median 2.1 years), 29 patients (76.3%) had a normal platelet count (>150 × 109/L) and 4 (10.5%) had a platelet count between 50 and 150 × 109/L. Only two of the five (13.2%) remaining patients who continued to have a platelet count less than 50 × 109/L had hemorrhagic manifestations necessitating intermittent therapy with corticosteroids. Conclusion: Laparoscopic or open splenectomy is a safe and effective procedure for children with chronic or refractory ITP and should be considered when medical management fails or causes excessive toxicity.

AB - Purpose: The aim of this study was to review the safety and efficacy of elective splenectomy in children with idiopathic (immune) thrombocytopenic purpura (ITP). Methods: The authors reviewed the medical records of children with ITP treated with elective splenectomy at Children's Medical Center of Dallas since 1961. Indication for splenectomy was symptomatic thrombocytopenia unresponsive to medical management. Results: Thirty-eight evaluable patients who had elective splenectomy for ITP were identified. Twenty-one (55%) were girls and 17 (45%) were boys. Twenty-two had splenectomy since January 1990. Age at diagnosis ranged from 6 months to 15.9 years (median 9 years), and age at splenectomy ranged from 3.6 to 16.4 years (median 11.8). Laparoscopic splenectomy was performed in 11 patients. No patient died and only one (2.6%) had postoperative hemorrhage. There were no other complications related to surgery. No cases of postsplenectomy sepsis were observed. At follow-up ranging from 1 month to 19.9 years (median 2.1 years), 29 patients (76.3%) had a normal platelet count (>150 × 109/L) and 4 (10.5%) had a platelet count between 50 and 150 × 109/L. Only two of the five (13.2%) remaining patients who continued to have a platelet count less than 50 × 109/L had hemorrhagic manifestations necessitating intermittent therapy with corticosteroids. Conclusion: Laparoscopic or open splenectomy is a safe and effective procedure for children with chronic or refractory ITP and should be considered when medical management fails or causes excessive toxicity.

KW - Immune thrombocytopenic purpura

KW - Laparoscopic splenectomy

KW - Postsplenectomy sepsis

KW - Splenectomy

UR - http://www.scopus.com/inward/record.url?scp=0034455617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034455617&partnerID=8YFLogxK

U2 - 10.1097/00043426-200003000-00013

DO - 10.1097/00043426-200003000-00013

M3 - Article

C2 - 10779029

AN - SCOPUS:0034455617

VL - 22

SP - 148

EP - 153

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 2

ER -